- Home
- PTGX vs HBI Comparison
PTGX vs HBI Comparison
Compare PTGX & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- HBI
- Stock Information
- Founded
- PTGX 2006
- HBI 1901
- Country
- PTGX United States
- HBI United States
- Employees
- PTGX N/A
- HBI N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- PTGX Health Care
- HBI Consumer Discretionary
- Exchange
- PTGX Nasdaq
- HBI Nasdaq
- Market Cap
- PTGX 3.7B
- HBI 2.2B
- IPO Year
- PTGX 2016
- HBI 2006
- Fundamental
- Price
- PTGX $61.52
- HBI $6.31
- Analyst Decision
- PTGX Strong Buy
- HBI Buy
- Analyst Count
- PTGX 9
- HBI 4
- Target Price
- PTGX $70.44
- HBI $6.50
- AVG Volume (30 Days)
- PTGX 925.0K
- HBI 6.0M
- Earning Date
- PTGX 11-06-2025
- HBI 11-06-2025
- Dividend Yield
- PTGX N/A
- HBI N/A
- EPS Growth
- PTGX N/A
- HBI N/A
- EPS
- PTGX 0.80
- HBI 0.25
- Revenue
- PTGX $209,180,000.00
- HBI $3,540,309,000.00
- Revenue This Year
- PTGX N/A
- HBI $1.61
- Revenue Next Year
- PTGX $248.17
- HBI N/A
- P/E Ratio
- PTGX $73.55
- HBI $13.17
- Revenue Growth
- PTGX N/A
- HBI 2.95
- 52 Week Low
- PTGX $33.31
- HBI $3.96
- 52 Week High
- PTGX $61.89
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- PTGX 61.66
- HBI 59.29
- Support Level
- PTGX $57.90
- HBI $6.23
- Resistance Level
- PTGX $60.40
- HBI $6.40
- Average True Range (ATR)
- PTGX 2.47
- HBI 0.14
- MACD
- PTGX 0.06
- HBI -0.06
- Stochastic Oscillator
- PTGX 95.59
- HBI 61.54
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated, as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina. Hanesbrands has agreed to be acquired by Canadian rival Gildan.